Key Takeaways in this ArticleThe global Artificial Intelligence in Genomics market is valued at USD 785.12 million in 2024 ...

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results ...

General industry are at the forefront of the ongoing technological revolution based on HPC, AI, electrified and automated ...

The agency declined to quickly release documents that would identify drugs made at some of the most troubled foreign ...

The U.S. Food and Drug Administration (FDA) says it plans to use artificial intelligence (AI) to help speed the approval of ...

The elimination of 3,500 full-time employees at the FDA risks undermining the very innovation and domestic capacity the ...

A Texas law promoting the Trump administration’s “Make America Healthy Again” agenda requires first-ever warning labels on ...

AACE pharmaceuticals was slammed in a warning letter by the FDA that cited significant violations by its contract manufacturer Brassica Pharma, including sanitary conditions and made up lab records.

The FDA issued a warning regarding the long-term use of two allergy medications. The medications are sold over-the-counter and prescribed. See below for details regarding the warning. Earlier this ...